Revolutionary Cancer Data Platform: Unlocking Immunotherapy Breakthroughs

Описание: Discover the groundbreaking 'Cancer Immunology Data Engine' (CIDE), a collaborative effort between HKUMed and the US National Cancer Institute (NCI). This cutting-edge platform integrates clinical data from nearly 6,000 cancer patients and multi-omics datasets from 17 cancer types, offering researchers unprecedented insights into cancer immunotherapy. Learn how CIDE is accelerating research and leading to exciting discoveries, including the identification of acyloxyacyl hydrolase (AOAH) as a powerful immunotherapy candidate.
Explore the mechanism by which AOAH activates the immune system to target cancer cells, and its potential as a novel anticancer modality in combination therapy. The video delves into the research team's findings, highlighting the significance of secreted proteins in immune modulation and their innovative approach to designing antibody-drug conjugates. Join us in celebrating this scientific advancement and its potential impact on cancer treatment worldwide.